Grant; Struan F.A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grant; Struan F.A..The latest application filed is for "identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same".

Company Profile

2.6.13

Grant; Struan F.A. - Philadelphia PA
Grant; Struan F.A. - Swarthmore PA
Grant; Struan F.A. - Reykjavik IS

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Identification Of Pediatric Onset Inflammatory Bowel Disease Loci And Methods For Use Thereof For The Diagnosis And Treatment Of The Same App 20220056529 - Hakonarson; Hakon ; et al.	2022-02-24
Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same Grant 11,111,539 - Hakonarson , et al. September 7, 2	2021-09-07
Identification of Pediatric Onset Inflammatory Bowel Disease Loci and Methods for Use Thereof for the Diagnosis and Treatment of App 20190218612 - Hakonarson; Hakon ; et al.	2019-07-18
Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes Grant 10,266,896 - Hakonarson , et al.	2019-04-23
Genetic alterations associated with type I diabetes and methods for use thereof for diagnosis and treatment Grant 9,926,600 - Hakonarson , et al. March 27, 2	2018-03-27
Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes App 20170044611 - Hakonarson; Hakon ; et al.	2017-02-16
Genomic Alterations Associated With Schizophrenia And Methods Of Use Thereof For The Diagnosis And Treatment Of The Same App 20160265053 - Hakonarson; Hakon ; et al.	2016-09-15
The Children's Hospital Of Philadelphia App 20160077079 - Grant; Struan F.A. ; et al.	2016-03-17
Genetic Alterations on Chromosomes 21Q, 6Q and 15Q and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes App 20150299793 - Hakonarson; Hakon ; et al.	2015-10-22
Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes Grant 8,575,120 - Hakonarson , et al. November 5, 2	2013-11-05
Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes Mellitus App 20120149016 - Grant; Struan F.A.	2012-06-14
Genetic Alterations on Chromosome 12 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes App 20120095074 - Hakonarson; Hakon ; et al.	2012-04-19
Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes App 20110286997 - Hakonarson; Hakon ; et al.	2011-11-24
Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same App 20110269688 - Hakonarson; Hakon ; et al.	2011-11-03
Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment App 20110243922 - Hakonarson; Hakon ; et al.	2011-10-06
Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus App 20090275043 - Grant; Struan F.A.	2009-11-05
Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus Grant 7,585,630 - Grant September 8, 2	2009-09-08
Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus App 20060286588 - Grant; Struan F.A.	2006-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.